Confirmed Presenting Companies

4C Medical's AltaValve is a supra-annular transcatheter mitral valve replacement (TMVR) system. The AltaValve system is intended to streamline the procedure to replace degenerated mitral valves compared to current solutions. AltaValve will also expand the population of patients eligible for treatment to include those who have undergone previous valve repair operations. 

Visit website.

Able Innovations is developing advanced medical devices to tackle challenges in transporting patients in healthcare. The ALTA system allows a single healthcare personnel to transfer patients, independently, in a safe, effortless, and automated fashion. The system eliminates the need to recruit additional staff, reduces musculoskeletal strain on providers, and provides a comfortable experience for the patient. 

Visit website.

Abram Scientific's mission is to deliver precision blood coagulation management with CoagCare, the world's first POC diagnostic platform capable of performing the entire spectrum of coagulation tests. The platform delivers hemostasis information rapidly by measuring blood viscoelasticity & density and maps the entire blood coagulation cascade from clot formation to lysis in under 10 minutes, while current coagulation diagnostic platforms require 30 to 60 minutes for a partial measurement.

Visit website.

Accelus, a worldwide leader in expandable spinal implant technology, is dedicated to enhancing surgical procedures and patient outcomes through innovative spinal solutions. The company’s commitment to excellence is evident in its advanced Adaptive Geometry™ technologies specifically designed for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted, percutaneous, and lateral spine surgeries.

Visit website.

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Visit website.

AccurKardia is an ECG-led diagnostics software company. We are unlocking the value of the ECG signal towards broad diagnostics coverage and disease management in cardiology and beyond. This holds the key to improving clinical outcomes and saving lives at a planetary scale.  AccurKardia's first product, AccurECG is an FDA cleared (Class II SaMD), cloud-based, and device agnostic software for fully automated ECG interpretation and detection for up to 13 arrhythmias. It is intended to assist cardiac monitoring companies in the analysis of ECGs recorded from holters, event recorders and cardiac telemetry devices.

Visit website.

Acera Surgical is a soft tissue repair company born from research and a focus on innovation. The company's electrospun, synthetic hybrid-scale fiber matrices are designed to be structurally similar to human tissue, resist enzymatic degradation, offer both flexibility and strength, and allow more effective healing before completely resorbing. 

Visit website.

Acoustiic is developing a high-intensity focused ultrasound (HIFU) system to non-invasively destroy tumors from outside the body. The company's solution can be used inside of today's MRI machines, allowing for a one stop diagnosis and treatment of early-stage cancers. The technology has been awarded Breakthrough Device designation by the FDA for the treatment of liver and pancreatic cancers. 

Visit website.

Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

Adhera Health is committed to helping people with chronic conditions and their family caregivers live healthier. The company has developed an AI-based Precision Digital Companion platform that delivers highly personalized, adaptive self-management programs that empower individuals to become the central resource in their health journey. 

Visit website.

Adialante is developing a silent, compact magnetic resonance imaging (MRI) system. 

Visit website. 

Adtec Healthcare are specialists in energy-based technologies. Cold plasma, which is electron dense, charged, ionized gas, that is safe to the touch has many different applications in healthcare. Adtech is commercializing a cold plasma solution, SteriPlas, for infection control applications. The use of cold plasma has been clinically proven to effectively treat biofilms, wounds, surgical site infections, and bacterial skin conditions as an alternative to antibiotics.

Visit website.

Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options.

Visit website.

AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).

Visit website.

AiZtech is a deep tech company applying artificial intelligence to a digital health platform called The iSelfie Test. This contactless diagnostic solution can detect medical conditions, like COVID-19, through the identification of biomarkers found on the outer surface of the eye. Deployed through a smartphone camera, AiZtech's technology enables rapid self-testing that can be administered at the point-of-care.

Visit website.

AKICept is advancing a clinical stage endovascular treatment to reverse ischemia reperfusion-caused acute kidney injury before permanent kidney damage, dialysis or mortality occurs. Our first product launch from a portfolio of accretive renal programs is expected in mid 2024. AKICept is seeking investment partners and strategic relationships with companies with a renal or endovascular strategic interest.

AliveCor was founded on the strengths of its proprietary technologies: AI-enabled, machine learning-powered ECG sensors capable of delivering medical-grade heart data anywhere and everywhere. The company's digital tools help patients access, manage, and share their data with cardiologists to better understand and manage their health.

Visit website. 

Allheartz is developing novel clinical AI-powered digital solutions to revolutionize home care in musculoskeletal (MSK) and sports health. The Software as a Medical Device (SaMD) platform innovated through the company's proprietary advanced computer vision applications turn an individual's smartphone into a medical-grade sensor. The platform is coupled with a remote HIPAA-compliant SaaS platform, to cut hospital costs while generating revenue through Remote Therapeutic Monitoring, simultaneously providing integrated, personalized, portable medicine that enables new highly scalable community-wide preventative care systems and value models.

Visit website.

AltaSeal is a minimally invasive, mechanical occlusive permanent contraception device. The device requires no anesthesia, no hormones and is a quick 30 minute procedure placed in the office setting using a standard or disposable hysteroscope.

Visit website.

Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. 

Visit website.

Alucent Biomedical is focused on transforming the way vascular disease is treated. The company is developing a proprietary catheter-based solution called Natural Vascular Scaffolding (NVS). The technology utilizes photoactivation of a small molecule drug delivered endovascularly to create a natural, stent-like scaffold using the body's own tissue and processes.

Visit website.

Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.

Visit website.

Ankasa is developing ART352-L as a novel regenerative medicine. ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries. The lead indication for ART352-L is the augmentation of autograft used in spinal fusion for the treatment of degenerative disc disease in intervertebral discs. 

Visit website.

Brio is a cavitation-enhanced low-power ultrasound lithotripsy system for office-based kidney stone treatment without anesthesia or fluoroscopy.  The mapping and locating ureteral catheter delivers patented Briosphere microbubbles and ensures beam alignment with the stone. The treatment can be delivered anywhere in a simple, 30-minute procedure. Brio addresses a massive urolithiasis market and huge access and health equity gaps with a reimbursable single use procedure kit.

Visit website.

Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.

Visit website.

Aqua Heart is developing an over-the-wire, single shot ablation solution for the treatment of atrial fibrillation (AFib). The technology combines radiofrequency and balloon elements to bring familiar thermal ablation via a new technique that is a safe and fast way to perform pulmonary vein isolation.

Visit website.

ARC Medical has the only liquid medical device which forms a temporary barrier film to prevent surgical adhesions throughout the entire surgical area. ARC Medical’s products are backed by positive Phase 1 clinical trial safety data in 76 participants and superior nonclinical efficacy data in head-to-head comparisons against 3 of the top marketed products. Surgical indications include gynecological & abdominal and orthopedic surgeries – knee, shoulder & hip.

Visit website.

Armis Biopharma has five approved products that are ready to be commercialized/licensed out in dental, wound care, animal health, disinfectant and a hammer toe implant with an exciting pipeline including a chemical/biologic decontaminate supported by a $20M DoD grant.

Visit website.

Arrayus Technologies is developing an image-guided ultrasound platform to enable incisionless therapeutic procedures. The company's technology uses intersecting beams of sonic energy to induce a range of biological effects, including tissue destruction, immunomodulation, drug delivery, and radiosensitization. Arrayus' solution is being developed for a broad range of oncological indications.

Visit website.

Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. 

Visit website.

Askel Healthcare is a Finnish medtech company seeking to transform surgical knee cartilage treatment and recovery. The company's COPLA implant is intended for the repair of full-thickness cartilage and bone-cartilage lesions in the knees of adult patients. The implant is a biodegradable polymer scaffold that allows for immediate full weight-bearing post-surgery.

Visit website.

Aspisafe Solutions is building a portfolio of integrated devices in the feeding space to create a personalized nutrition management system that solves the problems of Malnutrition and Ventilator Associated Events in the Intensive Care Unit (ICU). The devices include an antireflux feeding tube, and an intelligent pump that is able to derive minute by minute patient caloric requirements and provide targeted nutrition in a chaotic ICU environment.

Visit website.

Astron MedTech's TendMIN is a minimally invasive surgical device for the repair of acute Achilles tendon rupture and posterior bursitis. The TendMIN system combining with ultrasound or arthroscopy could reduce the size of the surgical wound - a key factor in improving outcomes when working near low circulation and slow healing conditions around the tendons.

Visit website.

The Atmo Gas Capsule is a unique ingestible capsule to provide unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, from liver disease to irritable bowel syndrome.

Visit website.

ATRO Medical's Artimis prosthesis is intended to provide patients who are too young for a knee replacement yet suffering from chronic knee pain with a viable solution. Artimis is a flexible, artificial meniscus that offers patients a less invasive alternative for treating chronic knee pain.

Visit website.

Avenda Health has built a multi-modal AI platform to bring superhuman abilities to surgeons and oncologists to power the future of cancer care. Our FDA-cleared inference engine, Unfold AI, build synthetic spatial maps of cancer incorporating the totality of a patient's diagnostic data and reveals invisible tumor extent. Physicians then use this information to improve clinical decision making and outcomes for patients.

Visit website.

Avisi is developing a portfolio of ophthalmic treatments based on a novel metamaterial technology. Its flagship product, VisiPlate, is a nanotechnology-enabled implant to treat glaucoma. Glaucoma is the world’s leading cause of irreversible blindness, affecting over 100M patients worldwide. VisiPlate has demonstrated competitive and differentiated performance in clinical trials OUS and aims to begin US clinical trials in 2024. VisiPlate has been recognized as a promising new technology by numerous organizations including the National Science Foundation, the Glaucoma Research Foundation, SXSW, Johnson & Johnson JLABs, Medtech Innovator Accelerator, UCSF Rosenman Institute, and many others.

Visit website.

BackStop Neural is developing a spinal cord stimulation (SCS) system that features a novel lead with ultra thin electrodes that are encapsulated with a softening polymer. The thinner leads of the device will open SCS up to a wider population of patients, including those with chronic pain of the upper trunk (e.g., neck pain, arms).

Visit website.

binx health's point-of-care diagnostic solution, binx io, is an FDA-cleared, CLIA-waved platform intended to enhance community health outcomes through access to affordable and rapid testing results. The company's system utilizes ultra-rapid polymerase chain reaction (PCR) amplification to obtain results in approximately 30 minutes. binx's diagnostic tests are initially focused on providing men and women with rapid access to results for sexually transmitted infections (STIs).

Visit website.

BioAro is a biotechnology company specializing in genomics, artificial intelligence and blockchain technologies. The company offers whole genome sequencing, microbiome testing, and software solutions to support clinical testing offerings and improve overall efficiency of healthcare practices.

Visit website.

BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and rewrites Eroom's law by leveraging the synergy between drugs and bacteria. BioCorteX exists because current drug development fails individuals by ignoring the (un)desirable drug-microbiome and pathophysiology-microbiome interactions. The company's lead product, Carbon Mirror™ uses deep tech to simulate how the colossal number of microbiota interact with a drug, de-risking preclinical studies and clinical trials, and replacing uncertainty with confidence for the patient.

Visit website.

BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. 

Visit website.

BioT's cloud platform simplifies the creation of a connected care ecosystem. The platform is self-service and requires no coding to connect medical devices, patient management portals, caregivers, and EHRs in an integrated space.

Visit website.

Bluedrop Medical have developed a patented system to reduce the burden of diabetic foot ulcers. The company's device, which is used from the patient's home, enables daily thermal and visual assessment of the feet. The condition of the soles of the feet are remotely monitored for signs of inflammation and skin damage, allowing clinicians to act sooner and prevent the development of foot ulcers.

Visit website.

BMI OrganBank is developing medical devices to eliminate the waitlist for lifesaving organ transplants through better organ assessment and transport technologies.   They are a seed stage company planning to initiate a clinical study of their flagship product within the next 12 months.

Visit website.

Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.

Visit website.

Bold Type mission is to help companies solve hard technical problems. The company specializes in transforming proof-of-concepts into protoypes, with a specific emphasis on digital health applications and connected, wireless medical devices.

Visit website.

Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine. 

Visit website.

Bottneuro is developing a non-invasive custom made tES/EEG device for the diagnosis and treatment of neurological diseases. The company employs a multidisciplinary approach that combines MRI, electroencephalography, and 3D printing which results in custom caps with precisely placed electrodes that provide personalized transcranial stimulation of specific regions of the brain. 

Visit website.

Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere.

Visit website.

Brainomix utilizes their expertise in artificial intelligence to develop software solutions to support precision medicine. The company's platform supports improved treatment decisions in cancer, lung fibrosis, and stroke using AI-powered imaging biomarkers. Brainomix's lead product, the Brainomix 360 Stroke Platform, is a comprehensive stroke imaging solution that fully automates stroke assessment.

Visit website.

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians.

Visit website.

Bryan Therapeutic's mission is to transform lives through research and natural products that generate and restore nitric oxide in the human body. The company is committed to advancing the understanding of nitric oxide's role in cardiovascular health and chronic diseases. 

Visit website.

BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion.

Visit website.

Butterfly Medical is developing an innovative treatment for benign prostatic hyperplasia (BPH). The company's implantable device can be inserted without surgery to provide relief from symptomatic BPH. The implantation procedure can be performed in under ten minutes in a physician's office using local anesthesia.

Visit website.

Caeli Vascular has developed a proprietary catheter-based multi-modal technology platform for the treatment of venous obstructive disease along the entire continuum of disease from early acute through chronic stages.  Chronic disease in particular remains a significant unmet need afflicting over 250,000 patients in the U.S. annually and is a significant financial burden on the healthcare system.  Caeli’s system provides infusion, clot fragmentation, and aspiration all within a confined treatment zone that minimizes embolization, bleeding, and blood loss during aspiration.

Visit website.

CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery.

Visit website.

CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins.

Visit website.

Essential tremor is a common neurological condition that effects millions of Americans. Cala Health has developed a novel therapy to reduce essential tremors without the side effects and risks associated with conventional treatment options. The company's TAPS (transcutaneous afferent patterned stimulation) therapy is delivered via the Cala klQ System, a wearable device worn on the wrist that provides on-demand therapy for hand tremor. 

Visit website.

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. 

Visit website.

CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.

Visit website.

Carecam is a digital health startup developing AI-powered solutions to identify gait disorders. The company has created a wearable-free solution that utilizes software and AI vision to analyze a patient's gate for neurology, orthopedic, and rehabilitation practices. 

Visit website.

For industry partners bringing innovative solutions to market: Caresyntax offers clinical data services, data science expertise, and AI-enabled tech modules to collect meaningful data straight from the point of care. The company's services capture value for the end-user and produce actionable insights to drive commercial growth and product development needs.

Visit website.

Caretaker Medical’s VitalStream™ Wireless Hemodynamic Monitoring platform is FDA-cleared to Non-invasively measure Continuous Beat-by-Beat Blood Pressure, Cardiac Output, Fluid Response, and other Advanced Hemodynamic parameters for ICU-quality continuous Remote Patient Monitoring across the full care continuum.

 The company’s patented Pulse Decomposition Analysis™ AI Technology, wearable Finger Sensor and remote App provide a wire-free alternative to invasive A-Lines and catheter-based hemodynamics and eliminates blind-spots between intermittent measurements to enable early warning of deterioration and guide better clinical decision-making.

Visit website.

CARI Health is developing a next-gen wearable remote medication monitoring solution. The device will enable clinicians to view medication levels in real-time, customize dosages for patients, and keep them compliant on life-saving medications. The first application will be for patients being treated with medications for opioid use disorder to ensure treatment compliance remotely, without frequent clinic visits.

Visit website.

Accidental catheter removal can produce significant costs and complications for patients and providers. With nearly 25% of hospitalized patients requiring an indwelling catheter, there is a need for a better solution to prevent burdensome complications associated with these commonly used devices. CathConnect's solution allows existing Foley catheters to be transformed into devices that can easily breakaway without causing complications for patients.

Visit website.

CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes.

visit website

Cellens is pioneering a novel diagnostic modality to distinguish cancer cells by "touch". The company's technology touches cells at the nanoscale level to reveal the unique fingerprints of cancer cells to support non-invasive cancer diagnosis from bodily fluids. 

Visit website.

A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Visit website.

Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.

Visit website.

CeQur is a medical device company committed to simplifying the lives of people with diabetes by commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Our product, CeQur Simplicity™, is an injection-free insulin delivery solution backed by years of research, patient trials, and clinical data.

Visit website.

Cerulean Scientific is developing a technology platform to address common challenges with implantable medical devices, including biofilm formation and thrombosis. 

Visit website.

Choice have developed small, implantable, wirelessly controlled valves as a contraceptive. Placed in a short, outpatient procedure, without the need for surgery, Choice valves open or close the fallopian tubes. The Choice system does not contain active electronics, batteries, or active chemical components.

Visit website.

CleanSite Medical is developing a novel connector disinfecting cap to prevent bloodstream infections associated with intravenous (IV) fluid and drug delivery. The company's proprietary ACTIV CAP Technology provides multiple disinfection modes for effectively minimize IV connector-related infections.

Visit website.

ClearCam develops technologies to improve the visual field-of-view during minimally invasive procedures. The company's ClearScope device is a disposable intra-operative lens cleaning device that continuous cleans and clears the lens of laparoscopic imaging systems during procedures, without having to remove the scope from the body cavity.

Visit website.

Coagulo is developing a portable testing system that can detect, identify, and quantify the effect of all currently prescribed anticoagulants. Using a small sample of whole blood, the platform can communicate actionable results to healthcare providers in under ten minutes. With Coagulo's technology, anticoagulant related adverse events and hospitalizations can be mitigated in sensitive patient populations. 

Visit website.

Cognivue is an FDA Cleared computerized cognitive assessment/test to assess the risk and changes in cognitive function that could be indicative of neurodegenerative diseases like dementia and Alzheimer's disease. The digital test measures and monitors 4 key cognitive domains via a 10-minute test that evaluates multiple neurofunctional parameters. The company offers two devices that provide clinicians with rapid or comprehensive testing options. 

Visit website.

Cognoa is a pediatric behavioral health company that is using artificial intelligence (AI) to power digital diagnostic and therapeutic products. The company's lead product, Canvas Dx, is an FDA-authorized diagnostic aid for early autism diagnosis. Other products in development at Cognoa include a therapeutic solution for autism, as well as diagnostic and therapeutic solutions targeted speech disorders, ADHD, and anxiety.

Visit website.

Cordex Systems is developing a novel cardiovascular diagnostic device known as the SmartCuff. It is a quick, simple, non-invasive device that takes the direct measurement of vascular health out of a surgical cardiac catheterization lab and makes it accessible to both a consumer at home and a clinician in the office setting. Known as the “vital vital sign”, the vascular compliance measurement taken by the SmartCuff may be used to track direct changes in vascular health as people engage in healthy lifestyle choices such as diet, exercise, stress reduction and smoking cessation or take prescribed medications to treat diabetes, hypertension, or abnormal lipids.

CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure. The device gently conforms to the heart's surface, applying compressions to increase cardiac output without contacting the blood - eliminating a major risk of thrombosis and stroke.

Visit website.

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery. 

Visit website.

Corstasis Therapeutics is a pivotal stage drug development company improving the utility of commonly used therapeutics for Heart Failure, Liver and Kidney disease. The company's mission is to deliver innovative options to help patients suffering from fluid overload recover at home. Its lead asset is a nasal diuretic intended to deliver IV similar therapy at home.

Visit website.

CorTec is developing the next generation of active implants for neuromodulation. 

Visit website.

Cosm Medical is leveraging AI and 3D Printing to become the world-leader in digitizing gynecological devices for precision care for pelvic floor disorders which affect half of all women in their lifetime. The process involves using either clinical assessments or ultrasound imaging to capture measurements. Artificial intelligence is then used to evaluate and provide clinicians with a personalized prosthetic design. Gynethotics, the personalized device is then created using an advanced manufacturing process like the established industries of custom dental and hearing. Their digital gynecology platform will be further supported by a digital health portal to help patients and providers improve access, compliance and outcomes throughout the continuum of care from obstetrics to menopause to surgery to elderly care.

Visit website.

Cuspa develops an artificial cusp designed to treat aortic insufficiency. The Cusper device attaches to the native aortic cusp using a nitinol grasper to prevent aortic insufficiency when the valve is open and ensure there are no leaks when the valve is closed.

Visite website

Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training. 

Visit website.

CxPrecision Medicine's NeuroFirst products are intended to reduce the complexity of diagnosing neurological disorders such as dementia, Parkinson's disease, and Alzheimer's. The company combines proteomics and machine learning to identify biomarkers that support personalized pharmaceutical management of patients and rule out neurodegenerative disorders.

Visit website.

Cygnus is a fully integrated Manifold/ hemostatic valve with complete bleed back control, arterial blood pressure measurement capability, air leak valve, all in a very compact blood-free system. There are 8 million endovascular interventions per year in the US, 16 million worldwide. The potential is $8 billion market.

Visit website.

CytoKind is a leader in using ultraviolet (UVB) light to treat immune disorders and improve outcomes for patients. By coupling their UVB technology with digital therapeutics, CytoKind aims to disrupt conventional care models for a broad range of acute and chronic disorders. 

Visit website.

Cytotheryx is developing a platform technology to increase the supply of available liver cells to advance clinical/therapeutic research. The company's bio-incubator technology produces consistent, high-quality primary human hepatocytes for use in drug discovery, disease-specific research, and the support of therapeutic applications such as liver assist devices, cell therapy, and other innovative treatments for liver diseases.

Visit website.

Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.

Visit website.

Delphinus Medical Technologies develop and commercialize ultrasound technologies specifically for the early detection of breast cancer. The company's flagship product, SoftVue, utilizes proprietary TriAD (triple acoustic detection) technology to capture reflection echoes from all directions around the breast while simultaneously gathering transmitted signals through the breast. SoftVue is specifically designed for use in women with dense breast, who have historically been inadequately served with conventional imaging modalities. 

Visit website.

Headquartered in Newport News, VA, Dilon Technologies, Inc. is a commercial stage women’s healthcare company which develops, manufactures, and sells innovative medical devices for detecting and assessing cancerous tumors, hemostasis, as well as portable video laryngoscopes while expanding its footprint across hospitals to broaden its offering into Biosurgery

Visit website.

Distalmotion is a medical device company founded in Lausanne, Switzerland with a mission to empower robotic surgery to more hospitals, surgeons, and patients worldwide.  Distalmotion is commercial with multiple installations across France, Germany, and Switzerland. Its surgical robot Dexter® is designed to deliver the benefits of robotics to more hospitals by being simple and straightforward to use, and more accessible as a modular, small format, and open system. As an open system, Dexter is designed to work natively with third party 3D imaging systems, energy devices, vessel sealers and other laparoscopic devices. It has a suite of fully wristed single use instruments providing the user with dexterity, precision of movement, reliable instrument performance, and lower reprocessing requirements.

Visit website.

DriQ Health is an internet-of-things (IoT) incontinence monitoring solution. The company's technology leverages sensor technology and artificial intelligence to monitor the state of a diaper or adult brief. DriQ Health provides end-users with real-time access to their data to providers work with their patients to improve their quality of life.

Visit website.

EBAMed develops innovative solutions for non-invasive and painless treatment of heart arrhythmias by using radiotherapy.  The company's technology consists of hardware and software components that enable non-invasive heart motion imaging that synchronizes in real-time with a therapeutic proton beam. 

Visit website.

eCential Robotics is a company specializing in bone surgical robotics. The company develops and markets a unique system unifying 2D/3D robotic imaging and real-time navigation and surgical robotics. The eCential Robotics platform is a universal system open to all implants and enabling third parties to develop surgical apps.

Visit website.

Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction. 

Visit website.

Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant.

Visit website.

Egg Medical was founded in 2014 to develop and market the next generation of radiation protection devices for hospital x-ray labs. The company's first product, the Egg Nest, reduces staff radiation exposure by >90%! We launched commercial sales in late 2019- and the R&D and commercial buildout continues.

Visit website.

Elixir Medical mission is to breathe new life into vascular interventions. To achieve said mission, the company is pursuing the development of its latest product, the DynamX Coronary Bioadaptor System. DynamX is designed to be a significant advancement compared to drug-eluting stents in patients with symptomatic ischemic heart disease. Other vascular interventions in development at Elixir include a site-specific antithrombotic therapy and a lithotripsy system to effectively manage calcium buildup. 

Visit website.

Endeavor Orthopaedics is an IP-protected platform technology company focused on the integration of fracture repair with soft tissue management of deforming forces. The combination of plate/screw and suture construct in one implant allows surgeons to address not only the osseous fracture repair but also the soft-tissue deforming forces, creating a bio-mechanical advantage during patient recovery.

Visit website.

Endo Tools Therapeutics develops and sells endomina, an endoscopic suturing platform to be used with standard endoscopes. Target indications are bariatric surgery, tumor resection and reflux treatment. The system is commercially available in the US and Europe; it has been used in more than 1,000 procedures with clinical results published for more than 200 procedures.

Visit website.

Endologix is dedicated to improving patients' lives through innovative interventions for the treatment of vascular disease. The company's portfolio consists of novel products for the treatment of peripheral artery disease (PAD) and aortic aneurysm repair (EVAR).

Visit website.

Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application utilizing advanced AI/ML functionality. Endoluxe is positioned to disrupt the market as a vendor agnostic platform that allows clinicians to utilize their existing investment in traditional scopes and supporting devices, utilizing a portable, integrated, and feature-rich platform at 1/10th the cost of legacy products. More information can be found at Endoluxe.com.

Visit website.

EndoSound is developing a system that converts any standard flexible endoscopes into a endoscopic ultrasound system. The EndoSound system makes ultrasound imaging and the information it provides accessible during diagnostic and interventional procedures of the digestive tract. 

Visit website.

Endovascular Engineering's Helo Thrombectomy System is a next generation clot removal technology for the treatment of acute sub-massive pulmonary embolism. The device addresses clot removal in a single pass as a result of a dual-action mechanism that combines aspiration with mechanical maceration to retrieve thrombus.

Visit website.

EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits.

Visit website.

EpiBone is using stem cell technology to grow new bone. At the heart of the company is its bioreactor, which creates the specific and delicate conditions necessary to cultivate stem cells into a personalized bone graft ready for implantation. The company creates custom scaffolds that are seeded with a patient's stem cells and incubated within the bioreactor to create living implants that allow patients to "grow their own bone".

Visit website.

Equilibrio radically transforms how we diagnose, treat and manage disease with inexpensive biosensors and scalable AI. Equilibrio’s continuous health monitor, based on 13+ years of research at Caltech, is a state-of-the-art, miniature, and affordable sensor.  Equilibrio enables entirely new physiological data streams that, when integrated with AI, will enable personalized and continuous remote care across a broad range of conditions.  For the first time patients and their doctors can have real-time insights into a range of vital health metrics, improving health outcomes, driving down cost and increasing health equity.  

Visit website.

ErgoSuture is the inventor of the groundbreaking roller-based suturing platform (RBS), which can be adapted across all surgical platforms, handheld and robotic, straight and flexible shafts, and makes suturing easier, safer, and faster. Our flagship product, Drive’N Roll, enables consistent suturing by reducing loss of needle control and allowing surgeons to manipulate a needle in hard-to-reach locations. We are preparing to launch Drive’N Roll in early 2025 after achieving the design freeze stage and filing multiple patents in the US and major international markets.

Visit website.

Exin Health's mission is to optimize efficiency and improve clinical outcomes in the operating room. The company is combining artificial intelligence with their extensive expertise in both clinical and operational aspects of surgery to provide cutting edge solutions that enhance operating room efficiency, safety and accelerate new staff training learning curve.

Visit website.

eXpanded eXistence HoloOPS platform combines mixed reality technology with artificial intelligence to optimize the surgical suite. The platform provides surgeons with on-demand access to data and visualizations previously inaccessible to them from within the OR.

Visit website.

Eyetronic Therapy is a novel solution to restore vision in patients suffering from neuropathies of the optic nerve, such as glaucoma. The Eyetronic solution utilizes non-invasive electrical stimulation of the optic nerve to stimulate the metabolism of the neurons, restore their function, and halt further cell degradation. 

Visit website.

Facet Dynamics is developing a next generation alternative to lumbar fusion procedures. Protected by 4 U.S. Patents, “Restore” is a unilateral lumbar facet replacement device, manufactured from the same materials used in today’s artificial hip and knee joints, and implanted in exactly the same fashion as that which occurs in contemporary lumbar fusion procedures. 

Factor 7 Medical provides expert services throughout the entire product lifecycle, from product inception to market launch and sales acceleration. The company specializes in navigating the complex medical device market landscape, helping clients bring their products to market efficiently and effectively.

Visit website.

FibriCheck combines photoplethysmography (PPG) and a smartphone to transform the way atrial fibrillation is detected and monitored. A medically certified algorithm processes the image captured data and obtain insights on heart rhythm as an alternative to electrocardiogram-based devices. 

Visit website.

Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, electromagnetic localization, and artificial intelligence-enabled mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy. 

Visit website.

Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery.

Visit website.

Fifth Eye Medical's early warning solution is improving the way hospitals are managing patients. The AHI System continuously collects and analyzes physiologic waveforms from standard ECG monitors to monitor and predict the risk of hemodynamic instability. Fifth Eye's software solution provides clinicians with the insights needed to prevent critical patient destabilizations that lead to crises.

Visit website.

Fisher Wallace Labs is a developer of wearable brain stimulation technologies for the treatment of depression, anxiety, insomnia, and other mental health conditions. Building upon the platform of the company's first-generation device, the second-generation OAK system utilizes a fixed output of transcranial stimulation, also known as cranial electrotherapy stimulation (CES). The technology has been shown to simultaneously lower cortisol and stimulate neurochemical production to reduce the symptoms of some of the most common mental health conditions.

Visit website.

FIZE Medical is developing a patient monitoring platform to measure the health status of patients based off real-time analysis of urine output. The company is currently developing three products that are all based around the base iUO monitoring device. The iUO Plus and iUO DUOFLO are advanced iterations of the base model model, enabling monitoring of acute kidney injury, shock prediction, intraabdominal pressure monitoring, and other vital monitoring measures.

Visit website.

Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs.

Visit website.

Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. The company's innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. 

Visit website.

FluidAI is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.

Visit website.

Fortuna Devices Inc has developed a novel device to address the two most common challenges in endovascular medicine: embolizations and crossing Chronic Total Occlusions.

Visit website.

ForwardVue Pharma is pre-clinical Ophthalmology start-up developing a unique drug/device combination product for treatment of chronic retinal disease, a leading cause of blindness worldwide. We have formulated a bioresorbable implant that delivers a safe and highly potent small molecule compound that demonstrates significantly improved potency in terms of treatment effect vs. current standard of care, in multiple pre-clinical models of retinal disease. A differentiated mechanism of action and durable delivery via standard intravitreal injection addresses significant unmet patient needs and will result in improved visual outcomes for patients.

Visit website.

Accelerating surgical capability for life science businesses via precision VR simulation.

Visit website.

Quantum Bio Modulation Therapy (QBMT) developed by G Life Quantum (“GLQ”) is a path breaking technology offering a holistic treatment and management of a range of pathologies. It combines Quantum Physics with Biology to treat the pathologies at the cellular level by correcting the ATP imbalances and thereby improving the cell metabolism, delivering quicker recovery and better quality of living. Treatment is delivered through application of rightly dosed non-thermal light in situ with the aim to induce an epigenetic response. QBMT has a wide application across multiple disease areas and new applications continue to be discovered, thereby offering a huge target market to GLQ. The company has prioritized to focus its initial products on the treatment of high mortality indications (such as ARDS, ACS and MoF) where the solutions can demonstrate significant improvement.

Visit website.

Galvanize designs and develops Pulsed Electric Field Systems to achieve meaningful and lasting therapeutic outcomes for patients. The company's Aliya platform is initially focused on the treatment of chronic bronchitis, oncology (e.g., NSCLC), and drug delivery. 

Visit website.

To control the entire pain cycle associated with major surgery, Gate Science is developing the RELAY system, a single platform that combines two analgesic modalities, sodium channel blockade and neuromodulation.  In current clinical studies, patients are controlling the intensity of neuromodulation in real time with the Gate Keeper phone app; we are in the process of linking Gate Keeper to the cloud to expand its functionality.

Visit website.

Current cardiac imaging modalities are either time (and cost) intensive, complex to operate, or require the use of ionizing radiation and other pharmaceutical agents, but even more importantly, the current standard of care utilizing these technologies largely focuses on identifying and measuring the downstream consequences of myocardial ischemia. In response, Genetesis has developed CardioFlux MCG, a 90-second, zero-contact scan that can detect and display the magnetic signal produced by the heart's electrical pacemaker activity. CardioFlux has been shown to be an objective non-invasive measure of ischemia that can detect ischemia at its earliest and most "invisible" stages.

Visit website.

GORYO Chemical is a clinical stage biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent. The company's fluorescent imaging agent for breast cancer, GCP-006, surgeons can identify positive margins in real-time on the lumpectomy specimen providing them information to enable them to decide if they should take additional tissue during the first lumpectomy surgery.

Visit website.

GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. 

Visit website.

Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.

Visit website.

HAPPE Spine LLC, is a medical device development company that designs and commercializes innovative spinal implants utilizing the patented HydroxyApatite Porous PolyEtheretherketone (HAPPE TM ) material platform. This technology combines the benefits  of hydroxyapatite for bone ongrowth, designed porosity for bone ingrowth, and the radiolucency of PEEK for post-operative radiographic assessment.

Visit website.

Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.

Visit website.

Headache Sciences is a clinical artificial intelligence company developing a Software as Medical Device (SaMD) solution to facilitate the diagnosis and monitoring of headache disorders. The technology utilizes EEG data and a proprietary algorithm to objectively diagnose migraines.

Visit website.

Headsafe is a brain health technology company focused on delivering technologies to optimize the measurement and management of neurological diseases. The company's NUROCHEK portable brain assessment system is cleared in the U.S. for the aid in diagnosis of mild traumatic brain injury (TBI) in conjunction with a standard neurological assessment. The NUROCHEK system uses Visual Evoked Potential (VEP) to measure aspects of the brain's electrical activity using EEG to examine brain function.

Visit website.

Healium medical is focused on advancing atrial fibrillation treatment with an innovative, no-contact guided ablation technology that allows simultaneous tissue ablation and lesion monitoring. The company's Echomplish platform features miniature transcatheter ultrasound technology to deliver precise ultrasonic energy for safe and rapid lesion formation. 

Visit website.

Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions.

Visit website.

Hidradenitis Suppurativa (HS) is an inflammatory skin disease that causes painful symptoms, particularly in difficult to cover parts of the body such as the armpits, buttocks and groin. Traditional dressings often fail to provide adequate protection, cause additional skin damage via adhesives, and are challenging for patients to apply. HidraWear is a wearable wound care system that provides HS patients with the necessary support to easily apply and manage their flares.

Visit website.

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. 

Visit website.

Icarus Medical is using the capabilities offered by 3D printing to bring patients personalized knee braces that more effectively reduce pain and improve function and movement activity. Using a 3D scan captured via a smartphone application, Icarus Medical produces custom braces in just two weeks to get patients comfortably ambulating.

Visit website.

iChor Vascular's goal is to become the 1st-line therapy for treating peripheral vascular occlusions. The company's ICHOR Panacea technology is a versatile, catheter-based solution that provides rapid reperfusion to occluded vessels, without the need for thrombolytic drug therapies or complex surgery. 

Visit website.

iiShield's mission is to improve short and longterm transplant outcomes. The company's lead product is a protective jacket for the kidney that aims to increase the amount working time available to surgeons during transplant procedures. The device protects kidneys from heating up during surgery, reducing the amount of thermal injury to these vital organs and minimizing risks of complications.

Visit website.

illumiSonics is a company based on new physics to illuminate deep data. The company's proprietary PARS® (Photon Absorption Remote Sensing) technology is a revolution in optical imaging. The company is currently developing and plans to commercialize its PARS advanced optical imaging systems for a wide range of pre-clinical and clinical applications.

Visit website.

ImaCor’s One Touch Hemodynamic Ultrasound combines imaging and monitoring in a portable package for ease-of-use by high acuity care teams, resulting in lifesaving course corrections in as much as 70% of patients vs standard of care. ImaCor’s miniaturized transesophageal ultrasound probe is FDA approved to be left in place for up to 72 hours, enabling direct visualization in the ICU of cardiac filling and function over time. To date, the technology has been used in over 20,000 patients with no complications. 

Visit website.

Imeka combines diffusion imaging and artificial intelligence to map white matter integrity to understand axonal loss, demyelination, and neuroinflammation. The company's non-invasive software is intended to improve the development of treatments for neurodegenerative treatments for conditions including Alzheimer's, Parkinson's, and Multiple Sclerosis.

Visit website.

Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.

Visit website.

inHEART advances precision medicine in cardiology with web-based AI solutions for personalized treatment, prevention, and screening for cardiac diseases.

Visit website.

InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics.

Visit website.

InnoTech Precision Medicine's mission is to bring high-performance diagnostics into the point-of-care. The company's diagnostic technology is based on the multi-modal and simultaneous detection of multiple classes of disease biomarkers from a single test to support accurate and early disease detection. The InnoTech Recognize test is a minimally equipped device that uses synthetic molecular biosensors to target multiple types of biomarkers that would traditionally require separate RT-PCR and antibody/antigen tests to detect multiple diseases.

Visit website.

Innova Vascular develops medical devices for the treatment of thromboembolism. The company's portfolio of vascular interventions include aspiration catheters and clot retrievers for the treatment of arterial and venous thromboembolism.

Visit website.

Innoventric id developing an easy-to-use, reliable, and safe percutaneous solution for the treatment of tricuspid regurgitation. The company's Trillium device uses cross-caval anchoring and a unique, multi-valve design to fit a wide range of anatomies without the risks of migration and leaks. 

Visit website.

InspireMD is a commercial-stage medical device company with a proprietary and innovative stent designed with an integrated embolic prevention system (EPS) for delivering neurovascular protection and stroke protection. The company's MicroNet technology is employed in its flagship product, CGuard EPS, a carotid stent platform designed to reduce stroke during and after carotid artery stenting.

Visit website.

Interventional Systems develops B2B and OEM surgical robotic platform solutions for minimally invasive surgery and percutaneous interventions. The company partners with other medical device manufacturers to offer them a customizable CE-Marked, FDA Cleared robotic platform that the partners can commercialize in combination with their therapeutic products (such as implants, needles, guidewires, etc.). Interventional Systems establishes and maintains the whole enabling processes and operations related to a robotics program, allowing the partner to focus on the commercialization efforts.

Visit website.

INVENIO's NIO Laser Imaging system uses Stimulated Raman Histology to image unprocessed tissue specimen without requiring sample preparation to enable histological evaluation of tissue outside of a laboratory. 

Visit website.

InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.

Visit website.

At IQ Endoscopes, we are creating pioneering, sustainable endoscopy technologies for the early diagnosis of diseases, helping to create a world where everyone has access to sustainable sterile endoscopy. Our Single Use Gastroscope is currently under regulatory review and this will be quickly followed by regulatory submissions for our single use colonoscope and sigmoidoscope in 2024. This compelling platform will enable IQ Endoscopes to offer healthcare professionals the most comprehensive range of single use technology to address the Gastro Intestinal market, whilst also ensuring key sustainability requirements are surpassed. With commercial activities set to begin in 2025, the organization is at a very exciting stage.

Visit website.

IRRAS is a commercial medtech company focused on developing innovative solutions to improve the management of post-operative fluids. The company's lead product, IRRAflow, is a next-generation intracranial fluid management system that features a dual lumen catheter and control unit to manage the drainage of excess fluid and intracranial pressure. 

Visit website.

Jana Care is developing self-administered testing technologies for chronic kidney, heart disease, and diabetes management. The platform enables patients to self-administer blood tests at home, and clinicians can remotely review the test results as needed. The platform’s capabilities aim to overcome distance and socioeconomic hurdles that currently hinder the timely detection and monitoring of chronic kidney and heart disease progression.

Visit website.

JelikaLite is a clinical stage medtech company developing a neuromodulation platform that addresses unmet needs in developmental pediatric disorders. The company's Cognilum device is a wearable therapeutic device that provides non-invasive brain stimulation using near-infrared light to improve responsiveness, speech, and social interaction in children with autism.

Visit website.

Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery.

Visit website.

Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions.

Visit website.

Kelvin Health uses a mobile thermal imaging camera to capture the head of the body and then analyzes those images with AI to detect anomalies related to vascular conditions. The company's technology offers new insights intended to improve the management of patients with vascular diseases. 

Visit website.

Bringing advanced testing technologies to the field of medicine, revolutionizing the way physicians test for and treat diseases.

Visit website.

Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care.

Visit website.

KitoTech Medical develops wound closure solutions based on its proprietary Microstaple Technology Platform - a novel wound closure solution that is an alternative to traditional staples and sutures. The microMend skin closure device protects and secures wound sites by anchoring to the skin using microstaples that can safely flex and move with the skin.

Visit website.

Kneevoice has designed a platform technology to capture the noise generated by the knee to evaluate cartilage damage and diagnose osteoarthritis. The platform consists of wearable knee sensors that records the sounds generated by the knee. This data is collected an analyzed by a neural network algorithm and generates a score evaluating the status of the cartilage.

Visit website.

Know Labs is committed to making a difference in the lives of millions of people around the world by developing convenient, affordable, non-invasive medical diagnostics solutions. The company's lead medical product is the KnowU, a wearable, non-invasive, needle-free device that uses proprietary dielectric spectroscopy to rapidly quantify blood glucose levels in real-time.

Visit website.

Larmor Bio is a biotechnology company advancing the development and commercialization of a proprietary bioplatform technology capable of high-resolution molecular phenotyping of various microsized biological samples. The company's approach obtains unprecedented levels of detail from live samples, without the need for harsh chemical reagents or extensive sample preparation.

Visit website.

Lattice Medical leverages their expertise in tissue engineering and 3D printing to develop innovative implants for soft tissue regeneration. The company's portfolio currently consists of two devices: RODIN, a matrix for regenerating the hypodermis, and MATTISSE, a 3D-printed resorbable breast implant.

Visit website.

Laxmi was founded to improve the quality of life for people living with diabetes. The company is developing a wearable diagnostic device that supports people living with Type I diabetes with real-time, accurate measurements.

Visit website.

Lazurite's ArthroFree system is a wireless surgical camera designed to address the limitations of traditional arthroscopic camera systems. Lazurite's technology removes the need for fiber-optic cables, helping to improve efficiency without compromising image quality. At the heart of the company's technology is the proprietary Meridiem light engine, a novel light source that does not require cables to transmit light and images during surgical procedures. 

Visit website.

Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries.

Visit website.

LEADOPTIK is developing an image-guided biopsy needle for early-stage lung cancer detection. Clinical challenges persist in integrating technology and tools to safely and effectively reach the peripheral lung. The company is introducing metasurface technology to caregivers, enabling real-time nodule assessment (RTNA) during biopsies.

Visit website.

Light Line Medical has developed a disinfection solution to prevent and treat catheter-associated infections, including those caused by antibiotic resistant-pathogens. The PhotoDisinfection System uses visible ultraviolet light delivered via a generator through the company's proprietary endotracheal, CVC, PICC, peritoneal dialysis, and Foley/urinary catheters to kill microbes and extend catheter use.

Visit website.

Limax has developed HEMOMax, a multifaceted solution to augment vascular reconstruction and wound management. The company's fully degradable hydrogel-based material has strong adhesion to difficult to attach surfaces like the surface of a bloody and beating pig heart, highlighting its unprecedented strong and flexible adhesion. The biomaterial can withstand high pressures and serve as a hemostatic agent in advanced bleeding scenarios. 

Visit website.

LINLINE Medical Systems has over two decades of experience in the design and production of medical lasers. The company's flagship product, MULTILINE, is a multi-application, modular platform equipped with five external high-intensity lasers intended for use in aesthetics, dermatology, and surgery. 

Visit website.

Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops.

Visit website.

Lionheart Health is using targeted bioelectric treatment to stimulate the body's natural healing and regeneration. Specific bioelectric signaling sequences have been shown to promote the expression of proteins for cosmetic purposes, as well as in pathways related to brain, muscle and nerve regeneration. The core stimulation technology has been purposefully implemented into a number of wearable devices targeting specific clinical indications. 

Visit website.

Liposphere has developed highly efficient biolubricants for medical applications. AqueousJoint, the main product under development with proven clinical safety and efficacy, is a local knee joint injectable for the treatment of Osteoarthritis. The compound acts as a mechanical boundary lubricant, which coats and protects the damaged joint surface from wear and ultimately reduces wear-induced pain.

Visit website.

Liquet Medical's mission is to transform the way vascular disease is treated. The Versus Catheter features dual tips that enables treatment of both lungs, in addition to real-time pressure monitoring sensors which allows physicians to optimize the amount of drug delivered while limiting potential side effects.

Visit website. 

LN Robotics is developing medical robots incorporating AI, big data, robotics, and biomaterials. The company’s AVIAR vascular robotic platform will initially target Percutaneous Coronary Interventions (PCI). The system uses a haptic interface and a unique multichannel mechanism to bring robotic precision and operator comfort to complex PCI interventions and beyond.

Visit website.

Lucid Diagnostics, a subsidiary of PAVmed, is developing solutions to improve the diagnosis and management of patients with esophageal diseases. The company's lead product, EsoCheck, is a non-invasive device that is intended to collect cells from the esophagus for testing. EsoGuard is a laboratory developed test (LDT) that uses next-generation sequencing to detect the presence of Barrett's Esophagus.

Visit website.

Lumicell is focused on innovative fluorescence-guided technologies for cancer surgery. The company's Lumicell Direct Visualization System is intended to guide the removal of residual cancer during surgery in real time. The platform technology consists of an optical imaging agent, a handheld device, and patient-calibrated tumor detection software that work together to find, view and guide the resection of residual cancer. Lumicell is currently investigating the use of its technology for use during breast cancer surgery.

Visit website.

Lungpacer Medical is focused on empowering patients to breathe on their own following mechanical ventilation. The AeroPace System harnesses the body's nervous system via catheter-based stimulation of the phrenic nerves to rebuild diaphragm muscle strength and wean patients off ventilators faster. 

Visit website.

MachineMD’s focus is the creation of automated, quantifiable, and standardized medical examinations to improve the quality and efficiency of healthcare. The company’s mission is to bring the diagnostic quality of trained tertiary care specialists into secondary and primary care sites for the diagnosis and monitoring of neurological disorders. At the core of the company’s approach is the evaluation of biomarkers related to eye movements and pupillary function using artificial intelligence and virtual reality. 

Visit website.

Magenta is a medical device company developing the world’s smallest heart pump - the Elevate™ Pump, meant to provide minimally-invasive support to the heart during acute episodes of dysfunction.

Magenta's Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) is a low-profile, high-flow arterial pump intended for temporary support of patients undergoing high-risk coronary interventions and for the treatment of patients admitted with cardiogenic shock.

Visit website.

Magloy Tech pioneers ResoMag®, an advanced bioresorbable magnesium technology revolutionizing implant solutions. Our innovative implants offer superior mechanical stability, promoting efficient bone healing, and eliminating the need for removal surgeries as they naturally resorb. With a focus on craniofacial and orthopedic trauma fixation, our product pipeline includes a cranial plating system and compression screws. Magloy Tech is dedicated to shaping the future of medical implants with sustainable, patient-centric solutions.

Visit website.

Makani Science makes bandage-sized wearable, wireless respiratory monitors. This platform technology uses stretchable electronic sensors to remotely monitor respiratory rate and volume. The device is intended to service multiple respiratory applications across all ages.

Visit website.

MALCOVA is utilizing proprietary computed tomography technology to provide a safe, comfortable, and effective imaging solution for the early detection and diagnosis of breast cancer, particularly in women with dense breasts. This technology is at the heart of a three-pronged approach that leverages the company’s advances in hardware, AI-based software, and patient-surrogate phantoms to yield a significant paradigm shift in the way breast cancer is detected and treated.

Visit website.

Matregenix is a leader in nanofiber technology, offering highly customizable nanofibrous materials for a diverse range of applications. The company's electrospinning machines and comprehensive contract development and manufacturing services make the company an ideal partner for companies seeking to bring their innovations to market.

Visit website.

MAUI Imaging has developed a unique hardware/software solution that uses ultrasound to simultaneously image multiple tissue types. This proprietary approach to imaging simplifies capture methodology and opens markets that were previously inaccessible to ultrasound due to a lack of volumetric data.

Visit website.

MDC is focused on improving cancer diagnosis and treatment with a novel robotic system. 

Visit website.

Mesh Suture is medical device company whose singular focus is to eliminate one of surgery’s most common, yet avoidable, problems – failed tissue repairs consequent to suture pull-through. The company's proprietary mesh suture technology was invented and developed by the company’s surgeon-founder as a creative outgrowth of more than 25 years of treating hernia, dehiscence, and tendon surgery complications caused by standard sutures in the fields of Plastic Surgery, General Surgery and Orthopedics. The company’s flagship product, Duramesh Mesh Suture, is a wound closure device that minimizes the concentration of tension at the suture-tissue interface and facilitates tissue integration to help surgeons close tissue defects securely and confidently.

Visit website.

Method AI is developing a surgical navigation platform to drive improved patient outcomes for robotic oncology procedures.  The company’s product will leverage deep tissue imaging and machine learning algorithms to provide physicians with real-time guidance against an AI-generated surgical plan.

Visit website.

MicroTransponder's Vivistim tool treats patients who experience upper limb problems after a stroke by delivering a small amount of neurostimulation to the vagus nerve to strengthen neural pathways in the brain during rehabilitation. The device comprises a small implanted battery and wires that internally connect to the vagus nerve in the neck. In addition to the Vivistim system, the company is evaluating its Serenity system as a treatment to treat and reduce tinnitus over time. 

Visit website.

MIMOSA has developed a tiny, hand-held device that democratizes the collection of tissue information in patients with peripheral vascular disease (PVD), wound care, diabetes, burns, and potential post-operative surgical complications. The device is capable of detecting tissue oximetry and temperature through the use of multispectral imaging, letting healthcare providers visualize beneath the skin, regardless of the patient's location.

Visit website.

MMD Technologies and its subsidiaries, EF Therapeutics and LifePulse Bioscience, provide a unique medical device for drug and gene delivery at the cellular level. The company is utilizing reversable electroporation to create permeability in cancer cells that enable the delivery of therapeutics to the cells while reducing or eliminating toxic side-effects.

Visit website.

Modulim’s mission is to help clinicians prevent the onset or escalation of diabetic foot ulcers—and other complications of vascular compromise. The Clarifi device is a noninvasive, non-contact, diagnostic wide-field imaging system that provides a fast, reliable, and objective method of assessing tissue oxygen saturation, hemoglobin quantity, and distribution at different depths in patients with compromised circulation.

Visit website.

MOLLI Surgical started in the OR after recognizing that surgeons were using dated technologies to treat cancer patients. The company's technology eliminates the need for wires and radioactive seeds for tumor localization with a magnetic-based system that is precise, reliable, and easy-to-use.

Visit website.

MultiplAI Health is developing an RNA-based, AI-driven screening technology to transform the way cardiovascular disease is screened and diagnosed. Using a whole blood sample, the company's RNAseq solution identifies molecular variances that indicate increased risk of a cardiovascular event. 

Visit website.

MUSE Microscopy™ has developed SmartPath MUSE Technology™, (SmartPath), an imaging platform that utilizes Microscopy with UV Surface Excitation (MUSE) technology. The SmartPath Instrument fast-tracks a tissue diagnosis within minutes from anywhere in the world utilizing fluorescence staining and UV microscopy, with fresh or formalin-fixed tissue to produce direct-to-digital images for pathologists.

Visit website.

MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Visit website.

Myocardial Strain Technologies is embarking on commercializing MyST-I, a non-blood contacting heart pump with promising results in human clinical trials and extensive animal studies.  MyST-I addresses a broad, unmet need for treating acute heart failure. The company is also developing a minimally invasive device, MyST-II, that will allow broader application by surgeons and interventional cardiologists.

Visit website.

N8 Medical is incorporating active compounds called ceragenins into medical devices to address unmet needs in patient care related to infections and other complications associated with medical devices. The company's lead product, CeraShield, is a biofilm-resistant endotracheal tube designed to reduce ventilator associated respiratory infections. N8 plans to employ the use of ceragenins into other medical devices that can benefit from the antimicrobial and anti-inflammatory properties of these small molecules. 

Visite website.

Nanoflex Robotics is developing next-generation, remote robotic solutions to enhance access to life-saving procedures. The company's robotic system uses advanced magnetic technology and ultra-flexible endoluminal tools to enable faster and easier navigation through tortuous blood vessels. Nanoflex's initial target application aims to shorten the time to treatment for acute ischemic stroke by making remote mechanical thrombectomies a reality.

Visit website.

NasaClip is an adjustable nosebleed rescue device designed to provide constant, comfortable, hands-free compression. The NasaClip device combines intranasal sponges and external nasal pressure to compliment and support the body's natural clotting process. 

Visit website.

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.

Visit website.

NED Medical is developing a new generation of oncology embolization therapies that have the potential to improve treatment options available to patients. The company's CombiSphere technology is a Y90 radioembolization therapy made with proprietary materials that optimize outcomes in a meaningful way, including improved dosimetry, optimized emission activity, and increased tumor coverage.

Visit website.

NeoLight is a medical device company advancing cutting edge technologies for the newborn care market. In addition to solutions for infant Jaundice and neonatal feeding, they have developed and market the world’s only FDA Cleared portable retinal cameras for imaging newborn eyes in 50+ countries.

Visit website.

Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.

Visit website.

NeuraLace Medical are the developer's of Axon Therapy, an FDA-cleared solution for the management of chronic pain. Axon Therapy uses noninvasive, magnetic pulse technology to treat chronic nerve pain in patients recovery from injury or surgical procedures.

Visit website.

NeuraSignal is using robotics and artificial intelligence to enhance ultrasound and uniquely capture blood flow data in real time. The company's NovaGuide platform provides the clinical team with vital hemodynamic information to guide diagnosis and improve the care of cardiovascular/neurovascular patients.

Visit website.

Neuro42 is developing a point-of-care, portable MRI platform backed by artificial intelligence and robotics. The platform will utilize low-field MRI imaging technology to enable imaging across departments, as well as support surgical procedures with live image guidance. 

Visit website.

Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG.

Visit website.

Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration.

Visit website.

Neurosoft Bioelectronics is building minimally invasive brain implants leveraging proprietary soft and stretchable electrodes for precise brain data recording & neurostimulation. Its main goal is to develop the first implantable neuromodulation device to treat severe Tinnitus, while exploring other indications with existing partners, such as epilepsy, or speech and motor disorders.

Visit website.

Neuspera is developing a technology platform for ultra-miniaturized implantable neuromodulation devices with the ability to power at depth, enabling less invasive procedure and more versatile solution. First application is a Sacral Neuromodulation System (SNM) designed to provide relief for Urinary Urgency incontinence (UUI) a symptom of Overactive Bladder (OAB).

Visit website.

The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

The Smart Neurostimulation System (SNS) delivers a precision neurostimulation therapy for the treatment of memory loss. It combines brain sensing with stimulation, and is securely connected to the cloud, using artificial intelligence to personalize the therapy for each patient. SNS generates massive data sets that help to accelerate the pace of therapy innovation.

Visit website.

NirvaMed is an early-stage medtech company developing a novel treatment for ST-Elevation Myocardial Infarction (STEMI). The company's solution is a rapid cooling system that can be deployed in parallel with standard devices for PCI to enable cardiac tissue preservation that addresses the shortcomings of previous hypothermic treatments. The device is delivered to the right side of the heart to prevent disruptions to standard left side of the heart procedures to provide ischemic relief prior to reperfusion therapy.

Visit website.

NOCIRA is developing a novel, non-invasive medical device that utilizes changes in air pressure, which the company calls Automated Variable Pulse Insufflation (AVPI), to stimulate sensory nerves in the ear to treat chronic and non-chronic migraines. NOCIRA's technology is being developed to expand research into migraine and other brain-based conditions to facilitate the development of safe and effective therapies. 

Visit website.

Noninvasix is using optoacoustic technology to monitor critically ill patients in the hospital. The company is developing a non-invasive device monitor patients for sepsis and septic shock in real-time. The device will enable healthcare providers to rapidly diagnose, monitor, and respond to these life-threatening conditions in patients.

Visit website.

Novadip is a clinical-stage company developing breakthrough stem cell-based tissue regeneration therapies to accelerate healing of large bone defects, bone non-union and spine fusion in a single treatment. Novadip’s proprietary and patented 3M³ platform is a three-dimensional, extracellular matrix that utilizes adipose-derived stem cells to deliver highly specific growth factors and miRNAs to mimic the physiology of the natural tissue healing.

Visit website.

NovaResp has developed a patented, AI-enabled software compatible with any positive airway pressure (PAP) machine to dramatically improve comfort and adherence to therapy for obstructive sleep apnea (OSA) patients. The company's platform software uses artificial intelligence and machine learning during PAP therapy to predict and prevent episodes of apnea before they would occur. As a result, personalized therapy can be delivered via PAP machines at a substantially lower, more comfortable air pressure levels, ensuring a significantly better patient experience and adherence to therapy.

Visit website.

NovaScan is an oncology company that has developed a platform technology for point-of-care ex vivo and in vivo cancer detection, assessment, and stratification. The company’s first product, nsCanary™, assess pancreatic and lung biopsy cores to determine if they contain pathologically relevant amounts of cancer. MarginScan™ -- the company’s second product – is used to assess margin in skin cancer excisions. Compared to alternatives, NovaScan products are far less expensive, faster, smaller, easier to use. They integrate seamlessly in workflow and are targeted for FDA Clearance in 2025. 

Visit website.

Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation.

Visit website.

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

Visit website.

NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative capabilities of nitric oxide (NO) to heal chronic wounds. Due to various factors, the body can lack the natural ability to produce and deliver sufficient NO. The company is investigating topical means to deliver NO exogenously to improve oxygen and nutrient flow to wounds, promote healthy inflammation, and stimulate the development of new microvessels and tissue.

Visit website.

nSight Surgical is a Stanford Biodesign, Stanford Start X, and Stanford Hospital Quality Improvement Project spinout, that has built a parallel video healthcare record based on truly objective data, using computer vision and AI, to decode the fundamental language of surgery in operating rooms. The company deploys camera networks into the surgical suite, to passively acquire data that is processed in real-time by its AI stack.  

Visit website.

NSite has developed a radiation-free solution to screen and monitor adolescent scoliosis. The company's technology can be deployed via a smartphone or tablet, enabling real-time, non-invasive scans and assessment of bone and joint health. 

Visit website.

Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. 

Visit website.

Addressing an unmet need in cancer care, NXgenPort harnesses the power of machine learning and remote patient monitoring with an implanted Smart Port that detects infection. Using optical sensors to measure blood cell counts, vitals, and heart function in vivo, NXgenPort will alert physicians to early signs of infection, determine a patient’s readiness for next treatment, and improve health equity and access.

Visit website.

NZ Technology is a medtech company specialized in the design and manufacture of advanced Human Machine Interaction products. The company's TIPSO device enables convenient, over-the-drape controls for physicians to navigate live and historical imaging records during surgical procedures. NZ Technology's HoverTap technology is a touchless solution for navigating device menus and elevators.

Visit website.

Omniscient is a pioneer in the field of connectomics - the precise mapping and analysis of an individual's unique brain connections. Harnessing the power of AI, Omniscient offers the only clinical platform commercially available today for mapping the brain’s higher cognitive and emotional regulation networks. Already transforming the way neurosurgeons approach brain surgery, Omniscient is poised to revolutionize the way we diagnose and treat a number of neurological disorders, such as brain tumor, Alzheimer’s disease, depression and TBI. 

Visit website.

OnPoint Surgical is revolutionizing orthopedic and neurosurgical spinal procedures with an Augmented Reality (AR) platform technology that superimposes virtual surgical guides and virtual spinal implants onto the surgeon’s visual field using see-through optical head-mounted displays. The technology offers many unique clinical and intra-operative benefits including intuitive use, improved hand-eye coordination, and impressive accuracy with the potential for better clinical outcomes.

Visit website.

Opsin Biotherapeutics is a joint venture that combines the expertise of Nanoscope Technologies with DesignPlex Biomedical to create unique products and alternatives to opioids and spinal cord stimulation for the treatment of chronic pain. Opsin's therapy specifically targets and activates the neurons that block pain through the delivery of light sensitive proteins that are activated via a low power LED light.

Visit website.

Orthomod's mission is to develop the next generation of orthopedic biomaterials. The company is combining natural and synthetic orthobiologics with polymer components to create implants for orthopedic and spinal surgery. 

Visit website.

Ossiform uses proprietary technology to 3D print patient-specific, natural, and resorbable bone implants. P3D Bone PSI is a fully resorbable bone graft substitute that features a unique bone-like porosity that remodels in real living bone. P3D Bone demonstrates osteoconduction with the rapid formation of new vascularized bone that osseointegrates with native bone, while simultaneously balancing bioresorption. 

Visit website.

OSSTEC's additive manufactured bone healing platform mimics the porous trabecular structure of bone, allowing for natural load transfer in joints that diminishes the negative effect of stress healing. With an initial focus on knee implants, the company is using its expertise in 3D printing to create implants that optimize fixation and provide a durable bone foundation. 

Visit website.

OsteoCentric Technologies is harnessing the power of mechanical integration to secure implants to bone. MI is a minimally invasive method to instantly secure and stabilize implants to a patient's bone. The company's lead product, UnifiMI, targets implant instability issues across a broad spectrum of orthopedic, spine, and sports medicine applications.

Visit website.

OUI Medical's micro-peritoneoscope is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery and biopsy forceps. The technology enables peritoneoscopy under local anesthesia at the point-of-care. 

Visit website.

Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.

Visit website.

Oxford Medical Products is developing a safe, effective, and affordable solution for weight loss. The Sirona solution consists of a self-expanding capsule that delivers a hydrogel into the stomach to create a sustained feeling of satiety. The hydrogel remains in the stomach for several days before degrading and being naturally digested. 

Visit website.

Perceptive Medical is creating a novel infusion pump designed for critical care areas like intensive care units and operating rooms.  The pump is capable of self-titrating medications to keep patients in very narrow target ranges, increasing quality of management while reducing bedside provider workload.

Visit website.

PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.

Visit website.

Percy is using technology to capture insights that are converted into science-backed behavioral changes to improve sleep.

Visit website.

Perimetrics' InnerView Artificial Intelligence Diagnostic System is a fast, non-invasive, pain-free, and radiation-free breakthrough diagnostic solution to detect cracks in the teeth. The solution utilizes Quantitative Percussion Diagnostics (QPD), or light, painless percussive tapping on the teeth to detect and diagnose damage and mobility issues in teeth. Data is processed in real time through a proprietary algorithm and shared easily within existing IT infrastructure. 

Visit website.

The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.

Visit website.

PictorLabs is a digital company developing an AI-powered virtual staining platform to accelerate clinical research and enhance histopathology. The company's proprietary platform can produce an infinite number of virtual stains from a single unstained tissue sample. These virtual samples are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and creating specialized virtual biomarker stains for high demand indications.

Visit website.

Pleioflow is a company with disruptive, patented technology in the field of "flow assist devices and transcatheter valves”. It is an 8.5 Fr device incorporating a novel cutting-edge transcatheter valve, combined with a pulsating balloon, able to deliver an excess of 3-5 Lt/min of flow in cardiac surgery and post-MI patients. The technology has demonstrated successful animal trial safety and efficacy results and is in clinical trials in Europe.

Visit website.

Polares Medical is developing a novel device for the treatment of mitral valve regurgitation. The device aims to replace the mitral posterior leaflet with a prosthetic that forms a superior seal with the valve's native anterior leaflet.

Visit website.

POLARIS^AR is pioneering a new era in surgery using mixed reality technology. The company is delivering what total joint robotic systems do in a mixed reality format. The company recently received FDA clearance for its first product, Stellar Knee, to measure, plan and guide a total knee arthroplasty procedure dynamically in real time.

Visit website.

Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration.

Visit website.

Positrigo is developing a functional positron emission tomography (PET) system with a small footprint at a fraction of the cost of current PET scanners. The company's NeuroLF system is an ultra-compact, dedicated PET system for applications in neurological (e.g., dementia, epilepsy) and neuro-oncology.

Visit website.

Powerful Medical is using artificial intelligence to empower clinicians to accurately diagnose cardiovascular diseases and treat cardiac patients with higher confidence. The company's lead product, PMcardio, employs deep learning algorithms that have been trained on over one million ECG records to identify over 30 cardiac diagnoses from a single 12-lead ECG tracing. 

Visit website.

Prana Thoracic is developing an innovative approach to improve the early diagnosis of lung cancer. The company is developing the ThoraCore System, a CT-guided, catheter-based approach to perform a nodulectomy. The technology will be capable of safely coring, capturing suspicious pulmonary nodules, while sealing lung tissue using bipolar radiofrequency energy.

Visit website.

Preci-Health SA is a Swiss-based medtech and AI company with a highly experienced team and an innovative product, ezdraw^TM that’s tackling the billion-dollar diagnostic industry. This solution, which is not yet registered on the market, offers a superior profile compared to existing blood sampling methods. The ezdraw^TM solution aims to support blood draws in medical-supervised centers as well as remotely, at home, eliminating the need for a trained phlebotomist.

Visit website.

PredxBio is converging spatial analytics and artificial intelligence to transform precision pathology. The PredxBio Platform is an analytical software that is capable of predicting tumor initiation, progression, and response to therapy - enabling better outcomes for patients. With PredxBio, drug discovery and clinical development is enhanced with spatially intelligent biology.

Visit website.

Pretika MedTech is reimagining outpatient and inpatient care with AI-powered Connected Wound Care technology.  The company's non-invasive, embedded medical device and wireless digital care cloud platform provides on demand or continuous imaging, sensor and data analytics for physicians and nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts.

Visit website.

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.

Visit website.

Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.

Visit website.

Smart drug delivery solution for the management and treatment of respiratory diseases. 

Visit website.

Qura is a preclinical medtech company that is addressing the burden of hypertension. The company's QSense platform enables the continuous collection of blood-pressure data in real-time to both patients and physicians. Qura's goal is to provide better information to effectively manage the disease. 

Visit website.

Next-generation beta ophthalmic applicator.

Visit website.

Radiatric was founded to develop and commercialize technologies that improve outcomes in patients with bacteremia, moderate to severe sepsis, and Septic shock. The RAD-01 device uses a unique non-pharmacological process to target and kill bacteria in the bloodstream. Radtric's system uses a proprietary light delivery system that combines visible and near-ultraviolet wavelengths to irreparably damage bacteria, without the risk of developing resistance to the technology because of its mechanism of action. The technology can be used in conjunction with antibiotics, dialysis, or hemoperfusion therapy to target a gram-positive and gram-negative bacteria.

Visit website.

Visit website.

RedDrop is a virtually pain-free, cost-effective, and easy-to-use whole blood and plasma collection system. The device, which can be used in home and healthcare settings, is capable of collecting high quality blood samples for diagnostic testing and remote clinical trials. 

Visit website.

Regain Laser Therapy is an US-based medical device company with a focus on regenerative medicine. Regain is poised to launch the Regain ‘Warrior’, the first product from a platform of proprietary, non-invasive, therapeutic lasers focused on accelerated healing of soft tissue injuries.

Visit website.

Relavo is developing technology to reduce the risk of catheter-related infections in home infusion therapies. Beginning with home dialysis, Relavo's PeritoneX System internally disinfects dialysis tubing to reduce infection risk and enable more kidney failure patients to receive quality care, at-home.

Visit website.

Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.

Visit website.

RevBio is using tetranite, a unique organic compound, as the base for its platform of bone adhesive biomaterials. The company's proprietary biomaterial is capable of multi-surface bonding, rapidly reaching mechanical stability, performing well in wet fields, and biodegrading at a controlled rate. RevBio's tetranite is under investigation for use in dental, cranial, trauma, spine, and animal health markets, with additional expansion opportunities identified.

Visit website.

The BISHEP intracanal system is Robotron's robotic-assisted platform for endoscopic spinal decompression, designed to be a safe and effective tissue-preserving alternative to spinal laminectomy.

Visit website.

S-Alpha therapeutics, Inc. is a company which is dedicated to developing software as medical device (SaMD) for health, delivering digital treatment solution to highly unmet medical needs disruptively in the world. Development of SAT-001, its pipeline leading SaMD solution for slowing the progress of pediatric myopia is on the track of pivotal study for efficacy and safety domestically, after completion of pilot study for Proof of Concept.

Visit website.

SafeBVM is a revenue-generating startup with an FDA 510(k)-cleared medical device. The corporation offers patented devices that regulate airflow during manual ventilation with resuscitator bags to deliver safe and optimal breaths. The technology minimizes the risk of complications associated with manual ventilation, such as gastric insufflation, by dynamically adjusting airflow and pressure based on patient-specific needs. Primarily targeting emergency medical services and healthcare providers, SafeBVM's solution bridges the gap between manual and mechanical ventilation, especially in critical and resource-limited settings.

Visit website.

SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. 

Visit website.

Samay uses a patented acoustic resonance technology to manage respiratory patients at-risk of exacerbations. Our first product, Sylvee, is a wearable sensor platform that continuously, passively and non-invasively monitors over 10+ lung function parameters in real time for 10x less than hospital-based testing

Visit website.

Scalpel's digital platform has been designed to address key challenges and improve the operation of the operation room. Using artificial intelligence (AI) and noninvasive sensors, Scalpel helps hospitals and providers manage inventory, optimize instrument trays, and provide detailed peri-operative data analytics.

Visit website.

ScreenPoint Medical's Transpara is an artificial intelligence (AI) solution to enhance early breast cancer detection and diagnosis. At the core of Transpara is FusionAI, a proprietary platform that merges pathology, clinical imaging, deep learning techniques, and X-ray physics. The software fits into existing workflows, providing radiologists with decision support that improve clinical accuracy, optimize workflow, and reduce workload. 

Visit website.

Sense is developing a non-invasive, wearable device that continuously monitors brain activity primarily in the intensive care unit. The device uses low power radiofrequency pulses to classify stroke and traumatic brain injury by subtype. 

Visit website.

Sensome is developing an innovative remote and non-invasive monitoring system for implantable medical devices allowing the characterization of the tissue surrounding the device. The company's sensing technology combines impedance-based micro-sensors with machine learning algorithms to identify biological tissues upon contact. The lead application for Sensome's technology is the Clotild connected guidewire for the treatment of ischemic stroke. 

Visit website.

Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges. 

Visit website.

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.

Visit website.

Should Innovations' mission is to provide innovative solutions that address current challenges in shoulder arthroplasty. The company's flagship product, the InSet Glenoid Implant has been designed to address the most significant issue in shoulder arthroplasty - glenoid loosening. Since the introduction of the initial InSet Implant, the company has gone on to introduce additional products to continue to address unmet needs in shoulder repair.

Visit website.

Our team at Silicon Valley Innovations, (SVI) brings over 30 years of experience in developing innovative, proprietary medical technology to market with a focus on designing products that improve patient lives. Our newest products encompass a creative, patented local drug delivery platform to address acute and chronic conditions in respiratory and feminine healthcare. Our unique platforms leverage the benefits of anatomically designed applicators to provide local drug delivery that can span the spectrum of patient care from cleansing and moisturizing tocomfortable delivery of OTC or prescription drug formulations.

Visit website.

Smartlens has developed a device to enable "on the go" measurement of intraocular eye pressure. The company's flagship product, miLens, is an electronics-free device that provides seamless measurement capabilities to improve the early diagnosis of eye disease, certain neurological disorders, and cancers. In addition to the miLens product, the company's THERmic device applies micro-doses of personalized treatments for the treatment of glaucoma.

Visit website

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.

Visit website.

Detecting flow compromise earlier using real-time, definitive, visual and quantitative blood flow monitoring — made possible with ultrasound.

Visit website.

Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system.

Visit website.

Sonogen Medical is a medtech company developing a next-generation ultrasonic solution for the healing of bone fractures. The device provides therapeutic and diagnostic advantages over current options, allowing healthcare providers to monitor efficacy while giving patients the convenience of at-home treatment. 

Visit website.

The first osseointegrative biomimetic knee cartilage implant.

Visit website.

SpectraWAVE’s mission is to provide unrivaled optical and computational insights to improve treatment and outcomes for patients with coronary artery disease. The HyperVue Imaging System provides AI-enabled next generation intravascular imaging for coronary stent optimization, and an anchor point for future innovation as a state of the art imaging hub for the cath lab.

Visit website.

SpinaFX Medical is committed to bridging the therapeutic gap (conservative vs. surgery) in the treatment of back and leg pain caused by a contained herniated disc. The company is pioneering a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce herniated disc volume. Clinical data shows that the solution leads to a reduction of disc volume, which relieves nerve root compression and herniated disc-related pain.

Visit website.

SpinePoint is developing the next generation of interbody devices for spine surgery. The company's initial products include a low stiffness cervical cage and a pedicle screw for spinal fusion.

Visit website.

Spinol alters the outcomes of spinal surgery using an innovative medical device called OctaSeal. The device seals a ruptured disc to reduce the rate of reherniation and secondary discectomy, a complication that affects 15% of discectomies and leads to costly, complex, and painful fusion procedures.

Visit website.

Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. 

Visit website.

Stimdia's pdSTIM system has been designed to electrically stimulate the phrenic nerves in a patient's neck to exercise the diaphragm during mechnical ventilation and minimize the impact of ventilation-induced diaphragmatic dysfunction. The temporary pacing stimulation is intended to support patients who have been ventilated for over 96 hours.

Visit website.

Stoparkinson's Earstim is a wearable electro-stimulation device intended to alleviate the symptoms of patients with Parkinson's disease without side effects.

Visit website.

SurePulse has identified a critical need for vital signs monitoring solutions for newborn babies. Current technologies have been adapted from devices for children and adults and are not suitable for newborn babies due to multiple factors. To address this limitation, the company has designed the SurePulse VS system, which uses a medical cap fitted with sensors to continuously monitor neonatal vital signs.

Visit website.

Sweetbio is a commercial-ready, medical device company with a novel, honey-incorporated wound care product. The company offers bioengineered wound products made with a collage derivative, Manuka honey, and hydroxyapatite. These solutions are indicated to manage acute and chronic wounds by reducing bacterial load and increasing the release of growth factors that progress wound healing.

Visit website.

Switfsure Innovations is addressing the challenges in caring for ventilated patients in critical care. The company's first product is being developed to improve oral care and reduce the incidence of ventilator-acquired pneumonia and its associated complications due to poor oral care. 

Visit website.

Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy. 

Visit website.

TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods. 

Visit website.

Tally Surgical is developing a next generation solution to track and manage retained sponges in the operating room. Tally is designed to be a reliable, easy-to-use, and cost-effective retained sponge solution. The product provides OR staff with an accurate count of surgical sponges more efficiently than current solutions.

Visit website.

Tau Medical's key pipeline, Pivot-Bridge, is an implantable, retrievable device designed to treat tricuspid regurgitation (TR). This device is inserted through a minimally invasive, reversible procedure to temporarily alleviate TR, improve patient conditions, and induce heart anatomical changes before tricuspid valve repair/replacement surgery. Additionally, Tau Medical's Pivot-Extend is a permanent solution for treating the TR.

Visit website.

TekCyte specializes in biocompatible medical device coatings with a variety of applications. The company's lead technology – BIOINVISIBLE – is a multifunctional coating that can be applied to many biomaterials to significantly reduce microbial biofilm associated with implants. Additional features of the BIOINVISIBLE coating include reduced thrombosis and restenosis in metal stents and reduced fibrosis associated with reconstructive polymer (breast, mesh) implants.

Visit website.

Tetrous, Inc. is a regenerative medicine company guided by a team of surgeons and regenerative medicine scientists, and led by experienced medical device executives. The company utilizes next generation advanced technologies for enthesis repair in sports medicine applications. The technology has potential application for all surgical repairs involving the re-attachment of tendon-to-bone, including Rotator Cuff, ACL, Achilles, and Hip. The first offering in the EnFix family of products is EnFix RC™ for rotator cuff repair.

Visit website.

The Patient Company is reimagining the way that patients are moved with SimPull. As the first new patient movement platform in over 20 years, SimPull automates the movement of patients, beginning with lateral patient transfer, and is the first patient movement device that stores and shares data on patient movement. This data provides insights that inform patient movement activities while simultaneously reducing liability for caregivers and hospitals in a new, unique way.

Visit website.

The Shape Sensing Company is pioneering a major advancement in minimally-invasive interventional procedures with its groundbreaking 3D guidance system using fiber optic shape sensing. The cutting-edge platform, which combines visualization software and devices, addresses the critical problem of harmful radiation exposure from x-ray use that affects both patients and medical staff.

Visit website.